Evidence map›Paper›PMID 31601204›Full record

ArticleMicrobial cell factories2019

Exploiting xylan as sugar donor for the synthesis of an antiproliferative xyloside using an enzyme cascade.

Manuel Nieto-Domínguez, José Alberto Martínez-Fernández, Beatriz Fernández de Toro, Juan A Méndez-Líter, Francisco Javier Cañada, Alicia Prieto, Laura I de Eugenio, María Jesús Martínez

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Expression and Characterization of Two α-l-Arabinofuranosidases fromInternational journal of molecular sciences · 2023
    Article
  3. Article
  4. Optimization of β-1,4-Endoxylanase Production by anMolecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Manuel Nieto-DomínguezBiotechnology for Lignocellulosic Biomass Group, Centro de Investigaciones Biológicas (CIB-CSIC), c/Ramiro de Maeztu 9, 28040, Madrid, Spain. manunieto@cib.csic.es.
José Alberto Martínez-FernándezBiotechnology for Lignocellulosic Biomass Group, Centro de Investigaciones Biológicas (CIB-CSIC), c/Ramiro de Maeztu 9, 28040, Madrid, Spain.
Beatriz Fernández de ToroNMR and Molecular Recognition Group, Centro de Investigaciones Biológicas (CIB-CSIC), c/Ramiro de Maeztu 9, 28040, Madrid, Spain.
Juan A Méndez-LíterBiotechnology for Lignocellulosic Biomass Group, Centro de Investigaciones Biológicas (CIB-CSIC), c/Ramiro de Maeztu 9, 28040, Madrid, Spain.
Francisco Javier CañadaNMR and Molecular Recognition Group, Centro de Investigaciones Biológicas (CIB-CSIC), c/Ramiro de Maeztu 9, 28040, Madrid, Spain.
Alicia PrietoBiotechnology for Lignocellulosic Biomass Group, Centro de Investigaciones Biológicas (CIB-CSIC), c/Ramiro de Maeztu 9, 28040, Madrid, Spain.
Laura I de EugenioBiotechnology for Lignocellulosic Biomass Group, Centro de Investigaciones Biológicas (CIB-CSIC), c/Ramiro de Maeztu 9, 28040, Madrid, Spain.
María Jesús MartínezBiotechnology for Lignocellulosic Biomass Group, Centro de Investigaciones Biológicas (CIB-CSIC), c/Ramiro de Maeztu 9, 28040, Madrid, Spain. mjmartinez@cib.csic.es.ORCID http://orcid.org/0000-0003-2166-1097
Centro de Investigaciones Biológicas Margarita Salas · ES

Funding

Comunidad de Madrid S2018/EMT-4459MINECO BIO2015-68387-RMINECO CTQ2015-64597-C2-2-PMINECO RTI2018-093683-B-I00
6 · The paper itself

Abstract

backgroundCurrently, industrial societies are seeking for green alternatives to conventional chemical synthesis. This demand has merged with the efforts to convert lignocellulosic biomass into value-added products. In this context, xylan, as one of main components of lignocellulose, has emerged as a raw material with high potential for advancing towards a sustainable economy.

resultsIn this study, the recombinant endoxylanase rXynM from the ascomycete Talaromyces amestolkiae has been heterologously expressed in Pichia pastoris and used as one of the catalysts of an enzyme cascade developed to synthesize the antiproliferative 2-(6-hydroxynaphthyl) β-D-xylopyranoside, by transglycosylation of 2,6-dihydroxynaphthalene. The approach combines the use of two fungal xylanolytic enzymes, rXynM and the β-xylosidase rBxTW1 from the same fungus, with the cost-effective substrate xylan. The reaction conditions for the cascade were optimized by a Central Composite Design. Maximal productions of 0.59 and 0.38 g/L were reached using beechwood xylan and birchwood xylan, respectively. For comparison, xylans from other sources were tested in the same reaction, suggesting that a specific optimization is required for each xylan variety. The results obtained using this enzyme cascade and xylan were similar or better to those previously reported for a single catalyst and xylobiose, an expensive sugar donor.

conclusionsBeechwood and birchwood xylan, two polysaccharides easily available from biomass, were used in a novel enzyme cascade to synthetize an antiproliferative agent. The approach represents a green alternative to the conventional chemical synthesis of 2-(6-hydroxynaphthyl) β-D-xylopyranoside using a cost-effective substrate. The work highlights the role of xylan as a raw material for producing value-added products and the potential of fungal xylanolytic enzymes in the biomass conversion.

Indexed as

Cloning, MolecularEndo-1,4-beta XylanasesGlycosidesNaphtholsPichiaTalaromycesXylans2-(6-hydroxynaphthyl)-O-beta-D-xylopyranosideEndo-1,4-beta XylanasesGlycosidesNaphtholsXylansAntiproliferativeEndoxylanaseResponse surface methodologyTransxylosylationβ-Xylosidase

Identifiers

PMID31601204
PMCPMC6788083
OpenAlexW2979771514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.